Trade FULC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Fulcrum Therapeutics, Inc. (FULC) is trading at US$3.85, up 0.00% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$292.22M. Over the past 52 weeks, FULC has traded between US$2.83 and US$15.74. On Syfe you can trade FULC with $0 commission and add it to your watchlist.
| Previous close | US$3.85 |
|---|---|
| Market cap | US$292.22M |
| 52-week range | US$2.83 – US$15.74 |
| Volume | 1.89M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.
Year: 2019
JPMorgan Downgrades Fulcrum Therapeutics to Underweight From Overweight
Jun 3, 11:28 AM · MT Newswires
Top Midday Decliners
Jun 2, 6:25 PM · MT Newswires
Top Premarket Decliners
Jun 2, 11:36 AM · MT Newswires
Piper Sandler Downgrades Fulcrum Therapeutics to Underweight From Overweight, Adjusts PT to $3 From $23
Jun 2, 11:22 AM · MT Newswires
Fulcrum Therapeutics, Inc. (FULC) stock is trading at US$3.85, 0.00% from the previous close of US$3.85.
The market cap for Fulcrum Therapeutics, Inc. (FULC) stock is approximately US$292.22M.
The 52-week high for Fulcrum Therapeutics, Inc. (FULC) stock is US$15.74.
The 52-week low for Fulcrum Therapeutics, Inc. (FULC) stock is US$2.83.
Fulcrum Therapeutics, Inc. (FULC) does not currently pay a dividend.
Stay on top of FULC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
